• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why STAAR Surgical Shares Are Trading Higher By Around 13%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

    4/4/24 1:21:21 PM ET
    $ABIO
    $ACHL
    $ADXN
    $ALUR
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Get the next $ABIO alert in real time by email

    Shares of STAAR Surgical Company (NASDAQ:STAA) rose sharply during Thursday’s session after the company issued strong preliminary first-quarter net sales guidance.

    STAAR Surgical shares jumped 13.3% to $44.30 on Thursday.

    Here are some other stocks moving in today's mid-day session.

    Gainers

    • TC Biopharm (Holdings) Plc (NASDAQ:TCBP) shares climbed 130.1% to $2.9790. TCBP announced execution of non-binding letter of intent for acquisition of NK Platform Technologies.
    • Allurion Technologies Inc. (NASDAQ:ALUR) gained 70% to $2.8801 after the company announced the commercial availability of its Virtual Care Suite in the United States. Also, Chardan Capital initiated coverage on the stock with a Buy rating and announced a $5 price target.
    • Tevogen Bio Holdings Inc. (NASDAQ:TVGN) shares climbed 40.6% to $3.58. Tevogen Bio, on Wednesday, appointed Tapan V Shah as Head of Investor Relations and Corporate Development.
    • HWH International Inc. (NASDAQ:HWH) gained 38.8% to $2.1765.
    • Candel Therapeutics, Inc. (NASDAQ:CADL) rose 36.3% to $2.2899 after the company announced interim data from the randomized phase 2 clinical trial of CAN-2409 in non-metastatic prostate cancer.
    • MacroGenics, Inc. (NASDAQ:MGNX) climbed 27.8% to $17.47. MacroGenics announced TAMARACK study data will not be presented at the ASCO Annual Meeting.
    • E-Home Household Service Holdings Limited (NASDAQ:EJH) gained 27% to $2.22.
    • Reliance Global Group, Inc. (NASDAQ:RELI) gained 24.6% to $0.46 after the company reported FY23 earnings.
    • Simulations Plus, Inc. (NASDAQ:SLP) rose 22.5% to $47.12 after the company posted better-than-expected results for its second quarter.
    • Vast Renewables Limited (NASDAQ:VSTE) gained 22.3% to $8.81.
    • Sportsman's Warehouse Holdings, Inc. (NASDAQ:SPWH) gained 21.3% to $3.7950 following a narrower-than-expected quarterly loss.
    • Gorilla Technology Group Inc. (NASDAQ:GRRR) jumped 19% to $0.8729 after the company reported a year-over-year increase in FY23 sales results.
    • Levi Strauss & Co. (NYSE:LEVI) shares rose 18.3% to $22.10 after the company reported upbeat earnings for its first quarter and boosted its 2024 earnings guidance.
    • NOVONIX Limited (NYSE:NVX) gained 15.4% to $2.83.
    • Zeta Global Holdings Corp. (NYSE:ZETA) climbed 14.8% to $12.09 after Morgan Stanley upgraded the stock from Equal-Weight to Overweight and raised its price target from $12 to $17.
    • Graphjet Technology (NASDAQ:GTI) gained 13.3% to $8.17
    • MaxLinear, Inc. (NASDAQ:MXL) gained 11.8% to $24.22. MaxLinear is expected to release its financial results for the first quarter 2024 after the closing bell on April 24, 2024.
    • Eiger BioPharmaceuticals, Inc. (NASDAQ:EIGR) gained 9.7% to $1.81. Eiger Biopharmaceuticals said on April 2, it received a notice from the Nasdaq that the company’s common stock will be delisted from Nasdaq.
    • Destiny Tech100 Inc. (NASDAQ:DXYZ) shares gained 8.8% to $29.39 after jumping 27% on Wednesday.
    • Addex Therapeutics Ltd (NASDAQ:ADXN) shares rose 8.2% to $16.76. Addex Therapeutics shares gained 18% on Wednesday after the company and funds affiliated with Perceptive Advisors announced the launch of Neurosterix..
    • MicroStrategy Incorporated (NASDAQ:MSTR) gained 7.4% to $1,724.42 amid a rise in Bitcoin.
    • Enphase Energy, Inc. (NASDAQ:ENPH) climbed 7% to $126.86.
    • HubSpot, Inc. (NYSE:HUBS) gained 6% to $664.51 following a report suggesting Alphabet is in talks with advisors about a potential offer for the company.
    • BlackBerry Limited (NYSE:BB) climbed 4% to $2.9223 after the company reported fourth-quarter results and issued FY25 guidance.

    Losers

    • eFFECTOR Therapeutics, Inc. (NASDAQ:EFTR) shares dipped 80.7% to $3.1801. The company announced topline results from the primary analysis of the randomized Phase 2 KICKSTART trial of tomivosertib combined with pembrolizumab in non-small cell lung cancer.
    • Keyarch Acquisition Corporation (NASDAQ:KYCH) fell 34.5% to $5.94.
    • View, Inc. (NASDAQ:VIEW) fell 29.4% to $0.3601. View shares fell on Wednesday after the company filed for Chapter 11 bankruptcy.
    • Achilles Therapeutics plc (NASDAQ:ACHL) declined 27% to $0.88 after the company reported fourth-quarter financial results. The company announced interim Phase I/IIa data on the use of clonal neoantigen reactive T cells from the CHIRON study in advanced unresectable or metastatic non-small cell lung cancer and the THETIS study in recurrent or metastatic malignant melanoma.
    • KWESST Micro Systems Inc. (NASDAQ:KWE) fell 24.4% to $0.85 after the company announced a proposed US public offering.
    • AXT, Inc. (NASDAQ:AXTI) fell 22.2% to $3.85. Traders circulated J Capital short report.
    • XTI Aerospace, Inc. (NASDAQ:XTIA) fell 20.9% to $3.64 after gaining 31% on Wednesday.
    • DigiAsia Corp. (NASDAQ:FAAS) fell 20% to $5.37.
    • Lamb Weston Holdings, Inc. (NYSE:LW) declined 17.5% to $83.40 after the company reported weak third-quarter results and cut its FY24 outlook.
    • Selina Hospitality PLC (NASDAQ:SLNA) dipped 17.5% to $0.0811.
    • Casa Systems, Inc. (NASDAQ:CASA) declined 16.3% to $0.0460. Casa Systems said the company and some units entered into asset purchase agreement with Lumine providing for sale and purchase of debtors' Cloud/Ran APA assets.
    • Kintara Therapeutics, Inc. (NASDAQ:KTRA) fell 15.2% to $0.1390. Kintara Therapeutics recently entered a merger agreement with TuHURA Biosciences.
    • Flora Growth Corp. (NASDAQ:FLGC) fell 13.5% to $2.3095 after the company reported the launch of proposed underwritten public offering of common shares.
    • GCT Semiconductor Holding, Inc. (NYSE:GCTS) fell 13.1% to $5.96.
    • SolarMax Technology, Inc. (NASDAQ:SMXT) dipped 10.9% to $11.75.
    • LAMF Global Ventures Corp. I (NASDAQ:LGVC) shares tumbled 10.2% to $9.97. LAMF Global Ventures Corp. I shares gained 3% on Wednesday after the company announced shareholders approved the previously announced business combination with Nuvo.
    • ARCA biopharma, Inc. (NASDAQ:ABIO) fell 8.9% to $2.96. ARCA Biopharma shares jumped 90% on Wednesday after the company and Oruka Therapeutics announced a merger agreement.
    • Aquestive Therapeutics, Inc. (NASDAQ:AQST) fell 8.9% to $3.9850 after the company filed for an up to $250 million mixed shelf offering.
    • OneMedNet Corporation (NASDAQ:ONMD) shares fell 8.6% to $0.97. OneMedNet shares jumped 34% on Wednesday after the company completed a securities purchase agreement to provide up to $4.54 million in funding.
    • Rent the Runway, Inc. (NASDAQ:RENT) fell 8.6% to $5.37.
    • Paramount Global (NASDAQ:PARA) fell 8.2% to $12.40 following a report suggesting the Ellison-led bid would require the company to raise new equity.

     

    Now Read This: Bitcoin Tops $66,000 Following Jobless Claims Data; Ethena Emerges As Top Gainer

    Get the next $ABIO alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ABIO
    $ACHL
    $ADXN
    $ALUR

    CompanyDatePrice TargetRatingAnalyst
    Strategy Inc
    $MSTR
    3/10/2026$175.00Buy
    B. Riley Securities
    Tevogen Bio Holdings Inc.
    $TVGN
    3/4/2026Buy → Hold
    D. Boral Capital
    Enphase Energy Inc.
    $ENPH
    2/25/2026$57.00Hold → Buy
    Jefferies
    Enphase Energy Inc.
    $ENPH
    2/4/2026$52.00Hold → Buy
    HSBC Securities
    Levi Strauss & Co
    $LEVI
    2/4/2026$25.00Buy
    Jefferies
    Enphase Energy Inc.
    $ENPH
    2/4/2026$41.00Underperform → Market Perform
    BMO Capital Markets
    Enphase Energy Inc.
    $ENPH
    2/4/2026$54.00Sector Perform → Outperform
    RBC Capital Mkts
    Enphase Energy Inc.
    $ENPH
    2/4/2026$35.00 → $40.00Hold
    TD Cowen
    More analyst ratings

    $ABIO
    $ACHL
    $ADXN
    $ALUR
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Broadwood Partners, L.P. bought $12,266,545 worth of shares (670,213 units at $18.30) (SEC Form 4)

    4 - STAAR SURGICAL CO (0000718937) (Issuer)

    3/13/26 7:59:59 PM ET
    $STAA
    Ophthalmic Goods
    Health Care

    Director Manning Paul B bought $2,999,996 worth of shares (550,458 units at $5.45) (SEC Form 4)

    4 - Candel Therapeutics, Inc. (0001841387) (Issuer)

    2/26/26 7:38:59 PM ET
    $CADL
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Executive Chair Craps Jan Eli B bought $2,432,330 worth of shares (50,000 units at $48.65) and was granted 317,647 shares, increasing direct ownership by 147% to 617,647 units (SEC Form 4)

    4 - Lamb Weston Holdings, Inc. (0001679273) (Issuer)

    2/6/26 5:10:07 PM ET
    $LW
    Packaged Foods
    Consumer Staples

    $ABIO
    $ACHL
    $ADXN
    $ALUR
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Tevogen CIO and Head of Tevogen.AI Mittul Mehta to Speak at Microsoft Fabric Community Conference (FabCon 2026)

    WARREN, N.J., March 18, 2026 (GLOBE NEWSWIRE) -- Tevogen ("Tevogen Bio Holdings Inc." or "Company") (NASDAQ:TVGN) today announced that Mittul Mehta, Chief Information Officer and Head of Tevogen.AI, will speak at the Microsoft Fabric Community Conference (FabCon 2026), taking place March 16–20, 2026, in Atlanta, Georgia. Mr. Mehta will participate in two sessions focused on the evolving intersection of data engineering and artificial intelligence: From Risk to Reward: Modernizing the Data Estate to Power Enterprise AIWednesday, March 18, 4:30PM – 5:05PM alongside Dipti Borkar, VP & GM OneLake & ISVs at Microsoft and Tripti Sethi, Data & AI Lead at Avanade.Agentic Data Engineering on Micr

    3/18/26 12:22:11 PM ET
    $TVGN
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    OneMedNet and Navidence Announce Strategic Collaboration: Empowering Pharma with Precision Real-World Data Insights

    MINNEAPOLIS, March 18, 2026 (GLOBE NEWSWIRE) -- OneMedNet Corporation (NASDAQ:ONMD) (the "OneMedNet," the "Company," "we," "us" or "our"), a leading provider of regulatory decision-grade, AI-ready Real-World Data (RWD), today announced a strategic collaboration with Navidence to help research organizations transform rapidly expanding healthcare data into clear, actionable real-world evidence. What This Collaboration Means for the Pharma Market Pharmaceutical companies face growing pressure to integrate high-quality RWD for regulatory submissions, post-market surveillance, and AI model training. Navidence's platform enables precise definition of health data needs via Computable Operationa

    3/18/26 8:50:00 AM ET
    $ONMD
    Biotechnology: Commercial Physical & Biological Resarch
    Health Care

    Sportsman's Warehouse Holdings, Inc. Schedules Fourth Quarter and Full-Year 2025 Earnings Conference Call

    WEST JORDAN, Utah, March 17, 2026 (GLOBE NEWSWIRE) -- Sportsman's Warehouse Holdings, Inc. ("Sportsman's Warehouse" or the "Company") (NASDAQ:SPWH) today announced that it will hold its quarterly conference call to discuss fourth quarter and full-year 2025 financial results on Tuesday, March 31, 2026, at 5:00 p.m. Eastern Time. A live audio webcast of the conference call will be available on the Company's investor relations website at http://investors.sportsmans.com/. A replay of the webcast will be available within two hours of the conclusion of the call through April 7, 2026, and can be accessed on the Company's investor relations website. About Sportsman's Warehouse Sportsman's Wareho

    3/17/26 4:10:00 PM ET
    $SPWH
    Other Specialty Stores
    Consumer Discretionary

    $ABIO
    $ACHL
    $ADXN
    $ALUR
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 3 filed by new insider Chandan Jayesh

    3 - Gorilla Technology Group Inc. (0001903145) (Issuer)

    3/18/26 6:03:22 PM ET
    $GRRR
    Computer Software: Prepackaged Software
    Technology

    SEC Form 3 filed by new insider Bower Bruce

    3 - Gorilla Technology Group Inc. (0001903145) (Issuer)

    3/18/26 6:03:07 PM ET
    $GRRR
    Computer Software: Prepackaged Software
    Technology

    SEC Form 3 filed by new insider Sennhauser Thomas

    3 - Gorilla Technology Group Inc. (0001903145) (Issuer)

    3/18/26 6:02:51 PM ET
    $GRRR
    Computer Software: Prepackaged Software
    Technology

    $ABIO
    $ACHL
    $ADXN
    $ALUR
    SEC Filings

    View All

    Amendment: SEC Form SCHEDULE 13D/A filed by Candel Therapeutics Inc.

    SCHEDULE 13D/A - Candel Therapeutics, Inc. (0001841387) (Subject)

    3/18/26 4:23:14 PM ET
    $CADL
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    SEC Form S-8 filed by Gorilla Technology Group Inc.

    S-8 - Gorilla Technology Group Inc. (0001903145) (Filer)

    3/18/26 4:10:27 PM ET
    $GRRR
    Computer Software: Prepackaged Software
    Technology

    SEC Form 10-K filed by AXT Inc

    10-K - AXT INC (0001051627) (Filer)

    3/17/26 4:32:12 PM ET
    $AXTI
    Semiconductors
    Technology

    $ABIO
    $ACHL
    $ADXN
    $ALUR
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for LIBERVANT issued to AQUESTIVE THERAPEUTICS INC

    Submission status for AQUESTIVE THERAPEUTICS INC's drug LIBERVANT (ORIG-1) with active ingredient DIAZEPAM has changed to 'Approval' on 04/26/2024. Application Category: NDA, Application Number: 218623, Application Classification: Type 9 - New Indication Submitted as Distinct NDA, Consolidated with Original NDA after Approval

    4/29/24 7:48:13 AM ET
    $AQST
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for MARGENZA issued to MACROGENICS INC

    Submission status for MACROGENICS INC's drug MARGENZA (SUPPL-5) with active ingredient MARGETUXIMAB-CMKB has changed to 'Approval' on 05/25/2023. Application Category: BLA, Application Number: 761150, Application Classification:

    5/29/23 4:45:45 AM ET
    $MGNX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for MARGENZA

    Submission status for MACROGENICS INC's drug MARGENZA (ORIG-1) with active ingredient MARGETUXIMAB-CMKB has changed to 'Approval' on 12/16/2020. Application Category: BLA, Application Number: 761150, Application Classification:

    12/20/20 4:31:01 PM ET
    $MGNX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ABIO
    $ACHL
    $ADXN
    $ALUR
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    B. Riley Securities initiated coverage on Strategy Inc with a new price target

    B. Riley Securities initiated coverage of Strategy Inc with a rating of Buy and set a new price target of $175.00

    3/10/26 8:42:16 AM ET
    $MSTR
    Computer Software: Prepackaged Software
    Technology

    Tevogen Bio downgraded by D. Boral Capital

    D. Boral Capital downgraded Tevogen Bio from Buy to Hold

    3/4/26 9:36:27 AM ET
    $TVGN
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Enphase Energy upgraded by Jefferies with a new price target

    Jefferies upgraded Enphase Energy from Hold to Buy and set a new price target of $57.00

    2/25/26 7:19:45 AM ET
    $ENPH
    Semiconductors
    Technology

    $ABIO
    $ACHL
    $ADXN
    $ALUR
    Financials

    Live finance-specific insights

    View All

    Sportsman's Warehouse Holdings, Inc. Schedules Fourth Quarter and Full-Year 2025 Earnings Conference Call

    WEST JORDAN, Utah, March 17, 2026 (GLOBE NEWSWIRE) -- Sportsman's Warehouse Holdings, Inc. ("Sportsman's Warehouse" or the "Company") (NASDAQ:SPWH) today announced that it will hold its quarterly conference call to discuss fourth quarter and full-year 2025 financial results on Tuesday, March 31, 2026, at 5:00 p.m. Eastern Time. A live audio webcast of the conference call will be available on the Company's investor relations website at http://investors.sportsmans.com/. A replay of the webcast will be available within two hours of the conclusion of the call through April 7, 2026, and can be accessed on the Company's investor relations website. About Sportsman's Warehouse Sportsman's Wareho

    3/17/26 4:10:00 PM ET
    $SPWH
    Other Specialty Stores
    Consumer Discretionary

    Tevogen Reaffirms Capital Discipline as Lead Investor Maintains Holdings and Company Limits Share Utilization

    Lead investor confirmed his intention to maintain his current shareholdings.Company does not anticipate using more than 1% of our authorized shares, including placement through the ATM, over the next 12 months or until the company becomes cash-flow positive.Approximately only one-fifth of total shares outstanding are in the tradable float when accounting for Tevogen's lead investor, directors and named executive officers.Company prioritizing long-term stock-based incentive program aligned with company milestones.Board of Directors continues to evaluate the potential declaration of a one-time special cash dividend to shareholders.Company continues to evaluate acquisitions that could generate

    3/13/26 2:45:00 PM ET
    $TVGN
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Strive Adds $50M of STRC to its Corporate Treasury

    Strategy Inc (NASDAQ:STRF, LuxSE: STRE)) ("Strategy") today announced that Strive, Inc. ("Strive") has allocated $50 million, representing over one-third of its corporate treasury, to STRC (Strategy's Variable Rate Series A Perpetual Stretch Preferred Stock). "We are encouraged to see innovative institutions continue integrating STRC into their treasury strategies," said Phong Le, Chief Executive Officer of Strategy. "Prevalon Energy, Anchorage Digital, and OranjeBTC have already added STRC to their corporate treasuries, and Strive is now the latest corporation to publicly announce doing so. Adoption continues to grow as more institutions recognize the role Digital Credit can play in mode

    3/11/26 9:00:00 AM ET
    $ASST
    $MSTR
    $STRC
    Computer Software: Prepackaged Software
    Technology
    Wholesale Distributors
    Industrials

    $ABIO
    $ACHL
    $ADXN
    $ALUR
    Leadership Updates

    Live Leadership Updates

    View All

    The $17 Billion Solar Maintenance Market Just Got a New Player From the Defense Sector

    Issued on behalf of VisionWave Holdings, Inc. Companies mentioned in this article: VisionWave Holdings (NASDAQ:VWAV), First Solar (NASDAQ:FSLR), Enphase Energy (NASDAQ:ENPH), SunPower (NASDAQ:SPWR), SolarEdge Technologies (NASDAQ:SEDG) Key Takeaways: VisionWave Holdings (NASDAQ:VWAV) subsidiary SolarDrone has acquired a 51% controlling interest in Junko Solar, an Israeli solar panel maintenance and cleaning company, and appointed its founder Amos Cohen as SolarDrone CEO.The global solar panel operation and maintenance market is valued at $17 billion in 2026 and projected to reach nearly $60 billion by 2035, growing at a 13.3% CAGR[1].First Solar inaugurated a $1.1 billion AI-enabled manuf

    3/17/26 9:00:00 AM ET
    $ENPH
    $FSLR
    $SEDG
    Semiconductors
    Technology
    Computer Software: Prepackaged Software

    Tevogen CEO Dr. Ryan Saadi Reaffirms Clinical Commitment During International Long COVID Awareness Month; Highlights Synergies of New Leadership Team and Digital Care Platform

    WARREN, N.J., March 11, 2026 (GLOBE NEWSWIRE) -- Tevogen ("Tevogen Bio Holdings Inc." or "Company") (NASDAQ:TVGN) today issued a statement from Founder and CEO Dr. Ryan Saadi regarding the company's progress in developing TVGN 489 for Long COVID, timed with International Long COVID Awareness Month. Following the appointment of a new leadership team on March 9, 2026, Tevogen is accelerating its "Biotech" and "Digital Health" verticals to move TVGN 489 into its next clinical phase. The company is currently evaluating the acquisition of Sciometrix and its Clinicus platform to provide real-world monitoring for Long COVID patients. Tevogen continues to prioritize the development of TVGN 489,

    3/11/26 3:15:00 PM ET
    $TVGN
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Rent the Runway Appoints Dhiren Fonseca as Executive Chairman

    NEW YORK, March 09, 2026 (GLOBE NEWSWIRE) -- Rent the Runway, Inc. ("Rent the Runway" or the "Company") (NASDAQ:RENT), the company that is transforming the way women get dressed, today spotlights the appointment of Dhiren Fonseca as Executive Chairman of the Board of Directors, who has served since October 2025. Fonseca is a seasoned business leader with a distinguished track record of scaling high-growth technology and consumer companies. His extensive experience spans private equity, travel, and digital commerce, making him uniquely positioned to guide Rent the Runway as it continues to innovate its platform, deepen its supplier relationships, and explore strategic partnerships. "Dhire

    3/9/26 9:15:00 AM ET
    $RENT
    Other Specialty Stores
    Consumer Discretionary

    $ABIO
    $ACHL
    $ADXN
    $ALUR
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Flora Growth Corp.

    SC 13D/A - Flora Growth Corp. (0001790169) (Subject)

    12/17/24 8:02:53 PM ET
    $FLGC
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13D/A filed by Flora Growth Corp.

    SC 13D/A - Flora Growth Corp. (0001790169) (Subject)

    12/17/24 8:01:40 PM ET
    $FLGC
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form SC 13G filed by Candel Therapeutics Inc.

    SC 13G - Candel Therapeutics, Inc. (0001841387) (Subject)

    12/17/24 12:30:40 PM ET
    $CADL
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care